Altogether, these in vivo studies suggest that, at least in the context of angiotensin II–induced cardiac hypertrophy and failure, loss of KLF2 in neutrophils leads to exacerbated cardiac neutrophil accumulation that in turn promotes cardiac hypertrophy and dysfunction. The gene discussed is KLF2; the disease is cardiac hypertrophy.